Analysts Set Bausch + Lomb Co. (NYSE:BLCO) Price Target at $19.14
Shares of Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twelve analysts that are covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month […]
More Stories
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...